Slide 1 Abstract No. 1234 A Phase I/II Study of the Angiogenesis Inhibitor Sorafenib in Cervical Cancer Patients Treated with Radiotherapy Naz Chaudary A. Fyles, C. Townsley,…
MF HO Yan Chai Hospital 20/4/2013 Background Frequently observed after treatment of pelvic tumour, e.g. CA prostate, CA cervix Due to microvascular injury and disruption…